Zade Roumayah, presented “Prevalence of Criteria for Genetic Testing According to the National Comprehensive Cancer Network Guidelines in a Contemporary Cohort of Post-Prostatectomy Men with Intermediate and High-Risk Prostate Cancer: The Henry Ford Health System Experience” for the Grand Rounds in Urology audience in October 2019.

How to cite: Roumayah, Zade Wafie Prevalence of Criteria for Genetic Testing According to the National Comprehensive Cancer Network Guidelines in a Contemporary Cohort of Post-Prostatectomy Men with Intermediate and High-Risk Prostate Cancer: The Henry Ford Health System Experience” October, 2019. Accessed Nov 2019. https://grandroundsinurology.com/prevalence-of-criteria-for-genetic-testing-according-to-the-national-comprehensive-cancer-network-guidelines-in-a-contemporary-cohort-of-post-prostatectomy-men-with-intermediate-and-high-risk-prostate

Prevalence of Criteria for Genetic Testing According to the National Comprehensive Cancer Network Guidelines in a Contemporary Cohort of Post-Prostatectomy Men with Intermediate and High-Risk Prostate Cancer: The Henry Ford Health System Experience – Summary:

Zade Roumayah details the results of a study at the Henry Ford Health System examining the prevalence of National Comprehensive Cancer Network criteria for genetic testing in post-prostatectomy men who had intermediate- to high-grade prostate cancer. With around a 50% response rate, the team found that around 27% of men fit these criteria, in categories including family history of breast and ovarian cancer, having two or more family members with a variety of cancer types, and personal cancer history.